is farxiga a glp 1 agonist GLP-1 Effects on Glucagon Suppression GLP-1 Receptor Agonists: Mascots &
Description
Long term outcomes of metabolic/bariatric surgery in adults

They are not meant to treat chronic conditions or provide long-term care

Glucagon-like Peptide-1 Receptor Agonist can slow the transit time of the gastrointestinal tract and may suppress appetite

The state obesity drug coverage landscape will continue to evolve as states respond to the recent announcement of the BALANCE model (see Box 1) and as states contend with budget challenges and the federal Medicaid spending cuts in the 2025 reconciliation law

Source: BioTrust
%25201.png)
Novos 2022 investor report saw an 84% growth in obesity-related sales between 2021 and 2022
